secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genprex, Inc. (GNPX)
CIK:        0001595248
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001437749-26-000995
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genprex regains Nasdaq minimum $2.5M equity compliance; one-year monitoring imposed
--------------------------------------------------------------------------------

- Received Nasdaq Compliance Notice on Jan 7, 2026, reaffirming compliance with Listing Rule 5550(b)(1).
- Mandatory Panel Monitor runs through Jan 7, 2027; any deficiency within that period triggers delisting without cure.
- If staff finds non-compliance during monitoring, delist determination letter issued; company may request new hearing.
- Previously disclosed non-compliance letter from Nasdaq on Aug 19, 2025 has been resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595248/000143774926000995/0001437749-26-000995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595248/000143774926000995/gnpx20260108_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-000995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer